CERT logo

CERT

Certara Inc.

$6.14
-$0.10(-1.60%)
51
Overall
60
Value
33
Tech
60
Quality
How is this score calculated?
Market Cap
$892.35M
Volume
2.78M
52W Range
$5.19 - $15.38
Target Price
$8.82

Company Overview

Mkt Cap$892.35MPrice$6.14
Volume2.78MChange-1.60%
P/E Ratio-74.0Open$6.20
Revenue$385.1MPrev Close$6.24
Net Income$-12.1M52W Range$5.19 - $15.38
Div YieldN/ATarget$8.82
Overall51Value60
Quality60Technical33

No chart data available

About Certara Inc.

Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Sector: Technology
Industry: Software Publishers

Latest News

Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX) and Certara (CERT)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Definium Therapeutics (DFTX) and Certara (CERT). Definium Therape...

Christine Brown6 days ago

Cerrado Gold Posts Record 2025 EBITDA as Minera Don Nicolas Ramps Up Underground Output

TipRanks Canadian Auto-Generated Newsdeska month ago

Certara Announces Upcoming Board and Audit Committee Change

TipRanks Auto-Generated Newsdeska month ago
ABCD
1SymbolPriceChangeVol
2CERT$6.14-1.6%2.78M
3
4
5
6

Get Certara Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.